FDA clears Aptitude’s latest Metrix molecular dx to test for COVID

The FDA granted Aptitude its first 510(k) clearance for the next-generation Metrix COVID diagnostic that features three-times greater sensitivity with 30% faster results that its original emergency use authorized test.